Socioeconomic Status and Cardiovascular Outcomes
2018/05/14 by William M. Schultz, Heval Mohamed Kelli, Heval M. Kelli +17 · 1,412 citations
Medicine · Social Sciences · #Cardiovascular Health and Risk Factors #Disadvantaged #Disease #Economic growth #Environmental health #Gerontology #Health disparities and outcomes #Medicine #Pathology #Physical Activity and Health #Population #Psychiatry #Psychological intervention #Psychosocial #Socioeconomic status
paper · pdf · doi:10.1161/circulationaha.117.029652
published in Circulation 137(20), 2166-2178 (Lippincott Williams & Wilkins)
openalex publication_date 2018/05/14 · openalex created_date 2018/09/07 · openalex updated_date 2026/08/05
Abstract
Socioeconomic status (SES) has a measurable and significant effect on cardiovascular health. Biological, behavioral, and psychosocial risk factors prevalent in disadvantaged individuals accentuate the link between SES and cardiovascular disease (CVD). Four measures have been consistently associated with CVD in high-income countries: income level, educational attainment, employment status, and neighborhood socioeconomic factors. In addition, disparities based on sex have been shown in several studies. Interventions targeting patients with low SES have predominantly focused on modification of traditional CVD risk factors. Promising approaches are emerging that can be implemented on an individual, community, or population basis to reduce disparities in outcomes. Structured physical activity has demonstrated effectiveness in low-SES populations, and geomapping may be used to identify targets for large-scale programs. Task shifting, the redistribution of healthcare management from physician to nonphysician providers in an effort to improve access to health care, may have a role in select areas. Integration of SES into the traditional CVD risk prediction models may allow improved management of individuals with high risk, but cultural and regional differences in SES make generalized implementation challenging. Future research is required to better understand the underlying mechanisms of CVD risk that affect individuals of low SES and to determine effective interventions for patients with high risk. We review the current state of knowledge on the impact of SES on the incidence, treatment, and outcomes of CVD in high-income societies and suggest future research directions aimed at the elimination of these adverse factors, and the integration of measures of SES into the customization of cardiovascular treatment.
Citations
Cited by
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- Trends in California Cardiovascular Disease Mortality: Sex–Race/Ethnicity Disparity and Income Inequality
- Associations between socioeconomic deprivation and pharmaceutical prescribing in primary care in England
- 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
- The importance of socio-economic determinants of health in the care of patients with peripheral artery disease: A narrative review from VAS
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- The individual and dyadic roles of neuroticism and conscientiousness in cardiac autonomic functioning of patients with cancer and their spousal caregivers
- The role of the built environment in promoting movement and physical activity across the lifespan: Implications for public health
- Association of number of siblings with preclinical markers of cardiovascular disease. The cardiovascular risk in Young Finns study
- Community daytime noise pollution and socioeconomic differences in Chicago, IL
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
- Application of the Australian Bureau of Statistics Socio-Economic Indexes for Areas in cardiovascular disease research: a scoping review identifying implications for research
- Poverty in the United States [wikipedia]
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [europepmc]
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [europepmc]
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [europepmc]
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. [europepmc]
- Stress-Associated Neurobiological Pathway Linking Socioeconomic Disparities to Cardiovascular Disease. [europepmc]
- Association of Lifespan Cognitive Reserve Indicator With Dementia Risk in the Presence of Brain Pathologies. [europepmc]
- Racial Differences in Cardiovascular Biomarkers in the General Population. [europepmc]
- Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy. [europepmc]
- Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults. [europepmc]
- Disentangling the Links Between Psychosocial Stress and Cardiovascular Disease. [europepmc]
- Heterogeneous trends in burden of heart disease mortality by subtypes in the United States, 1999-2018: observational analysis of vital statistics. [europepmc]
- Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group. [europepmc]
- Risk Factor Burden and Long-Term Prognosis of Patients With Premature Coronary Artery Disease. [europepmc]
- Call for Action to Address Equity and Justice Divide During COVID-19. [europepmc]
- Trends in Cardiovascular Risk Factors in US Adults by Race and Ethnicity and Socioeconomic Status, 1999-2018. [europepmc]
- Sex Differences in Peripheral Artery Disease. [europepmc]
- Social Determinants of Cardiovascular Disease. [europepmc]
- Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke. [europepmc]
- Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates. [europepmc]
- Family income and cardiovascular disease risk in American adults. [europepmc]
- Wearable Devices in Cardiovascular Medicine. [europepmc]
- Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020. [europepmc]
- Development and Validation of the American Heart Association's PREVENT Equations. [europepmc]
- Social Determinants of Health and Disparities in Hypertension and Cardiovascular Diseases. [europepmc]
- Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study. [europepmc]
Related